(2011; 2 pages)
Adverse drug reactions (ADRs) pose a serious risk to the achievement of positive therapeutic outcomes. Spontaneous ADR reporting, a key component of pharmacovigilance systems is not only an excellent means to document uncommon ADRs, but also allows the risk-benefit assessment for old and new medications. Despite ADR reporting being a professional obligation, underreporting by healthcare professionals is commonplace and it is estimated that only 6% of all ADRs are reported globally. Whether pharmacists have a role in national drug monitoring programmes varies by country. For example, in the United States, 70% of the ADR reports submitted to the Medical Watch programme were generated by pharmacists. However, in Nordic Countries pharmacists are not in a position to directly report ADRs.